Amyotrophic lateral sclerosis (ALS) is a relatively rare but fatal neurodegenerative disease with the progressive loss of both upper and lower motor neurons. Although electromyography, imaging and multi-omics technologies have suggested numerous functional, structural, circulating and microbiota markers for ALS, no clinically validated markers have, as yet, been identified. Here we summarize the advances to characterize markers underlying ALS pathophysiology as well as their potential use in diagnosis, prognosis and therapy.
Keywords: Amyotrophic lateral sclerosis; Marker; Motor neuron; Multi-omics; Pathophysiology.
Copyright © 2023 Elsevier Inc. All rights reserved.